Saturday 7 November 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.59%
- EPS
- +23.8%
- Free cash flow
- −0.77%
- Total debt
- +13.4%
Quarter to September 2026, against a year earlier
496.04
11.44
−2.25%
Follow HCA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.54 | 13.05 | 16.27 | 16.45 |
+8 more quarters Free account |
P/S ratio |
1.16 | 1.10 | 1.39 | 1.46 | |
P/FCF ratio |
15.33 | 14.34 | 13.35 | 14.35 | |
P/Operating CF |
20.53 | 36.82 | 52.54 | 46.79 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.79 | 1.73 | 2.00 | 2.06 | |
EV/EBITDA |
8.87 | 8.50 | 9.75 | 9.98 | |
EV/Operating CF |
12.64 | 12.11 | 11.76 | 12.33 | |
EV/FCF |
23.63 | 22.46 | 19.29 | 20.26 | |
Quick Ratio |
0.63 | 0.77 | 0.64 | 0.73 | |
Current Ratio |
0.82 | 0.99 | 0.83 | 0.97 | |
Net Debt/EBITDA |
12.62 | 12.06 | 12.35 | 11.02 | |
Debt/Assets |
79.58% | 78.61% | 78.15% | 76.57% | |
Debt/Equity |
(10.98) | (15.49) | (16.13) | (16.78) | |
Asset Turnover |
1.28 | 1.27 | 1.26 | 1.26 | |
Operating CF/Net income |
2.83 | 1.37 | 1.24 | 1.26 | |
Capex/Depreciation |
(1.41) | (1.29) | (1.19) | (1.61) | |
Interest Coverage |
4.88 | 5.15 | 4.92 | 5.60 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.23% | 40.98% | 43.35% | 42.84% | |
Intangible Assets out of Total Assets |
0.18 | 0.17 | 0.17 | 0.17 | |
Share Based Compensation of Revenue |
0.67% | 0.42% | 0.45% | 0.51% | |
Graham Net Nets |
(0.57) | (0.57) | (0.46) | (0.43) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
7.39% | 7.66% | 6.14% | 6.08% | |
Free Cash Flow Yield |
6.52% | 6.97% | 7.49% | 6.97% | |
Revenue per Share |
92.50 | 91.73 | 85.47 | 82.54 | |
Operating CF per Share |
20.79 | 10.59 | 9.01 | 9.98 | |
Capex per Share |
(6.32) | (5.58) | (5.00) | (6.30) | |
Free Cash Flow per Share |
14.46 | 5.01 | 4.00 | 3.68 | |
Cash per Share |
4.23 | 4.59 | 4.20 | 4.40 | |
Shareholders Equity per Share |
(21.43) | (14.55) | (13.32) | (11.72) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(21.43) | (14.55) | (13.32) | (11.72) | |
Free Cash Flow |
3,104.00 | 1,104.00 | 895.00 | 870.00 | |
Working Capital |
(3,560.00) | (122.00) | (3,206.00) | (567.00) | |
Capital Expenditures |
(1,357.00) | (1,231.00) | (1,119.00) | (1,489.00) | |
Net Current Asset Value |
(51,832.00) | (49,269.00) | (48,376.00) | (47,708.00) | |
EV/EBIT |
11.64 | 11.10 | 12.70 | 12.94 | |
Capex to Sales |
0.07 | 0.06 | 0.06 | 0.08 | |
Price to Operating Income |
7.55 | 7.08 | 8.79 | 9.16 | |
| Other line items | |||||
Average Receivables |
10,968.50 | 11,370.00 | 11,206.00 | 10,809.00 | |
Average Payables |
4,827.50 | 4,501.00 | 4,647.00 | 4,467.50 | |
Average Inventory |
1,702.00 | 1,727.00 | 1,737.50 | 1,695.00 | |
Average Assets |
61,599.50 | 61,393.00 | 60,624.00 | 60,116.50 | |
Average Common Equity |
(3,379.00) | (2,223.50) | (1,708.00) | (1,108.00) |
Columns are period end dates · fundamentals updated 2 Nov 2026